Janus Henderson Group’s Lyell Immunopharma LYEL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,425
| Closed | -$94.2K | – | 2559 |
|
|
2024
Q3 | $94.2K | Hold |
3,425
| – | – | ﹤0.01% | 2513 |
|
|
2024
Q2 | $98.3K | Sell |
3,425
-30
| -0.9% | -$861 | ﹤0.01% | 2501 |
|
|
2024
Q1 | $155K | Sell |
3,455
-1
| -0% | -$45 | ﹤0.01% | 2466 |
|
|
2023
Q4 | $134K | Sell |
3,456
-5
| -0.1% | -$194 | ﹤0.01% | 2502 |
|
|
2023
Q3 | $101K | Hold |
3,461
| – | – | ﹤0.01% | 2517 |
|
|
2023
Q2 | $220K | Buy |
+3,461
| New | +$220K | ﹤0.01% | 2407 |
|